Evaluation of the Paradoxical Association Between Lipid Levels and Incident Atrial Fibrillation According to Statin Usage: A Nationwide Cohort Study

Hyo‐Jeong Ahn; So-Ryoung Lee; Eue-Keun Choi; Seung‐Woo Lee; Kyungdo Han; Soonil Kwon; Seil Oh; Professor Gregory Lip

doi:10.12997/jla.2023.12.1.73

Related publications

Article2022

PO-627-03 PARADOXICAL ASSOCIATION BETWEEN LIPID LEVELS AND INCIDENT ATRIAL FIBRILLATION ACCORDING TO STATIN USAGE

Hyo‐Jeong Ahn, So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Sun-hwa Kim, Seil Oh, Professor Gregory Lip

Article2020

The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study

Stephanie L. Harrison, Professor Gregory Lip, Deirdre A. Lane, Mirosław Mastej, Sławomir Kasperczyk, Maciej Banach, Jacek Jerzy Jozwiak

Article2021

Relationship between lipoproteins, thrombosis, and atrial fibrillation

Wern Yew Ding, Majd Protty, Ian G. Davies, Professor Gregory Lip

Article2023

Statin use improves the outcomes in patients with atrial fibrillation: A population-based study

Jiayi Huang, Mei‐Zhen Wu, Qing Ren, Hung‐Fat Tse, Professor Gregory Lip, Kai Hang Yiu

Preprint2018

Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment

Eeva Sliz, Johannes Kettunen, Michael V. Holmes, Clare Oliver‐Williams, Charles Boachie, Qin Wang, Minna Männikkö, Sylvain Sebért, Robin Walters, Kuang Lin, Iona Y. Millwood, Robert B. Clarke, Liming Li, Naomi Rankin, Paul Welsh, Christian Delles, J. Wouter Jukema, Stella Trompet, Ian Ford, Markus Perola, Veikko Salomaa, Paul M Ridker, Zhengming Chen, Debbie A. Lawlor,